1 |
Warnock DG. Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 2001;322:302-7.
DOI
ScienceOn
|
2 |
Rose BD. Clinical physiology of acid-base and electrolyte disorders. 5th. New York: McGraw-Hill, 2001:822-930.
|
3 |
Schwalbe RA, Weiner D, Wingo CS. Regulation of renla potassium transport. In: TD DuBose, LL Hamm, editors. Acid-base and electrolyte disorders. 1st. Philadelphia: Saunders, 2002:365-80.
|
4 |
Kone BC. Hypokalemia. In: TD DuBose, LL Hamm, editors. Acid-base and electrolyte disorders. 1st. Philadelphia: Saunders, 2002: 381-93.
|
5 |
Gennari FJ. Hypokalemia. N Engl J Med 1998;339:451-8.
DOI
ScienceOn
|
6 |
Ellison DH. Salt-wasting disorders. In: TD DuBose, LL Hamm, editors. Acid-base and electrolyte disorders. 1st. Philadelphia: Saunders, 2002:311-33.
|
7 |
Jackson EK. Diuretics. In: LL Brunton, JS Lazo, KL Parker, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 11th. New York: McGraw-Hill, 2006: 737-69.
|
8 |
Cabizuca SV, Desser KB. Carbenicillinassociated hypokalemic alkalosis. JAMA 1976;236:956-7.
DOI
ScienceOn
|
9 |
Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-34.
DOI
ScienceOn
|
10 |
McMahon GT, Dluhy RG. Glucocorticoidremediable aldosteronism. Cardiol Rev 2004; 12:44-8.
DOI
ScienceOn
|
11 |
White PC. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 2001;322:308-15.
DOI
ScienceOn
|
12 |
Sica DA. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 2005;10:23-9.
DOI
ScienceOn
|
13 |
안효섭. 홍창의 소아과학. 제9판. 대한교과서(주) 2007:133-6.
|
14 |
Furgeson SB, Linas S. Mechanisms of Type I and Type II Pseudohypoaldosteronism. J Am Soc Nephrol 2010; doi: 10.1681/ASN. 2010050457
|
15 |
Weiner ID, Wingo CS. Hyperkalemia. In: TD DuBose, LL Hamm, editors. Acid-base and electrolyte disorders. 1st. Philadelphia: Saunders, 2002:395-412.
|